Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...
The Department of Health and Human Services is re-evaluating a $590 million contract for avian influenza mRNA vaccines that ...
American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Last year, the administration of former President Joe Biden allocated more than $800 million to combat bird flu in livestock.
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
As H5N1 spreads rapidly, wild birds remain at risk. Here’s what to know about the outbreak and how to keep your feathered ...
While the company has conditional approval, the USDA will still have to approve its larger use before farmers can give it to ...
Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...
The administration also told Vaxart Inc. to halt its research on an oral Covid vaccine, Bloomberg reports. In related news, the policy to cull poultry caught in H5N1 bird flu outbreaks will not be ...
Trump administration weighs new strategy to curb bird flu as public fumes over egg prices, shortages
Which came first, rising egg prices or President Trump’s lagging poll numbers on the economy? It doesn’t matter much to the ...
The U.S. government awarded Moderna $590 million in January to ... of a pre-pandemic mRNA-based vaccine against the H5N1 avian influenza. "While it is crucial that the U.S. Department of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results